StocksMedium•11 November 2026•
1 min read
Analysts Raise Carlsmed Price Targets Following Strong Q3 Results
Key Facts
1Analysts raised price targets for Carlsmed after the company beat Q3 estimates and hiked its full-year revenue guidance.
2Carlsmed shares jumped 19.5% in response to the strong financial performance and updated future outlook.
Analysts raised price targets for Carlsmed after the company's third-quarter results beat estimates and led to a hike in full-year revenue guidance. Benzinga reported that Carlsmed shares jumped 19.5% in response to the strong financial performance and updated outlook.
The company achieved 65% year-over-year revenue growth, prompting an upward revision of its fiscal year 2026 revenue guidance to a range of $78M to $80M. CARL closed at $14.71 on November 10, 2026.